Clinical Research Division, Fred Hutch
Dr. Victor Chow is a clinical researcher who creates new treatments for patients afflicted with relapsed or refractory lymphomas, seeking to combine cellular therapies with novel, targeted agents. He is keen on developing new conditioning regimens for autologous stem cell transplantation, in which patients receive high-dose chemotherapy or radiation treatment to rid the body of malignancy, followed by an infusion of their own blood stem cells. In addition, Dr. Chow is interested in how to best care for patients whose lymphomas unfortunately return after receiving a type of genetically engineered immunotherapy called chimeric antigen receptor, or CAR T-cell, therapy, and how to best sequence cellular therapies for such individuals. As such, Dr. Chow is a physician who cares for patients with Hodgkin and non-Hodgkin lymphomas and those undergoing hematopoietic stem cell transplantation.
Assistant Professor, Division of Medical Oncology
University of Washington School of Medicine
Fellowship, Hematology-Oncology, University of Washington/Fred Hutchinson Cancer Research Center, 2019
Residency, Internal Medicine, University of Washington, 2016
Internship, Internal Medicine, University of Washington, 2014
MD, University of Washington School of Medicine, 2013
BS, Biology-Physiology, University of Washington, 2008
Novel conditioning regimens for autologous stem cell transplantation
Combination approaches utilizing cellular therapies and immunotherapy
Relapsed, refractory Hodgkin and non-Hodgkin lymphoma
Pathogenic blood bacteria rare in transplant patient subset (Fred Hutch Science Spotlight)
Fred Hutch at ASH – When CAR T-cell therapy fails: Treatment strategies in lymphoma (Fred Hutch News Release)
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email email@example.com or call 206.667.2210.